Moreover, the overexpression of miR-26b was reported to target four different oncogenes: TATA-box binding protein associated factor 12 (TAF12), protein tyrosine phosphatase type IVA, member 1 (PTP4A1), checkpoint with forkhead and ring finger domains (CHFR), and STE20-related kinase adaptor beta (ALS2CR2), to suppress the cell growth and the induction of apoptosis associated with the invasiveness and metastasis of CRC cells. This evidence concerns the gene TAF12 and colorectal carcinoma.